Rubius Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/13/2023

Shares

412,218

Value ($000)

70

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/13/2023	70	0.0%	412,218	12/31/2022
2022 Q3	11/14/2022	188	0.0%	435,646	9/30/2022
2022 Q2	8/12/2022	370	0.0%	435,646	6/30/2022
2022 Q1	5/13/2022	4,246	0.0%	770,636	3/31/2022
2021 Q4	2/11/2022	7,457	0.0%	770,370	12/31/2021
2021 Q3	11/12/2021	14,295	0.0%	799,508	9/30/2021
2021 Q2	8/13/2021	19,852	0.0%	813,297	6/30/2021
2021 Q1	5/12/2021	19,041	0.0%	718,553	3/31/2021
2020 Q4	2/12/2021	4,433	0.0%	584,132	12/31/2020
2020 Q3	11/13/2020	3,039	0.0%	606,615	9/30/2020
2020 Q2	8/13/2020	3,547	0.0%	593,283	6/30/2020
2020 Q1	5/14/2020	2,452	0.0%	551,161	3/31/2020
2019 Q4	2/13/2020	4,872	0.0%	512,870	12/31/2019